Skip to main content
Sergio Fazio, MD, Endocrinology, Portland, OR, OHSU Hospital

SergioFazioMD

Endocrinology Portland, OR

Professor, Medicine, Vanderbilt University School of Medicine

Dr. Fazio is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Fazio's full profile

Already have an account?

  • Office

    Oregon Health and Science University
    3181 SW Sam Jackson Park Road
    Portland, OR 97239
    Phone+1 503-418-9008
  • Is this information wrong?

Education & Training

  • Sapienza University of Rome
    Sapienza University of RomeClass of 1983

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 2016 - 2020
  • TN State Medical License
    TN State Medical License 1994 - 2014

Awards, Honors, & Recognition

  • Board of Directors American Board of Clinical Lipidology, 2015
  • Elected Member Association of American Physicians, 2011
  • Elected Member American Society for Clinical Investigation, 2001

Publications & Presentations

PubMed

Journal Articles

  • The Present and Future JACC State-of-the-Art Review the Evolving Future of PCSK9 Inhibitors  
    Robert S Rosenson, Sergio Fazio, ScienceDirect
  • Increased Cardiovascular Risk in Hypertriglyceridemic Patients with Statin-Controlled LDL Cholesterol  
    Sephy Philip, Sergio Fazio, The Journal of Clinical Endocrinology and Metabolism
  • Effects of 12 Weeks of Treatment with Intravenously Administered Bococizumab, a Humanized Monoclonal Antibody Blocking Proprotein Convertase subtilisin/kexin Type 9, i...  
    Charles M Baum, Sergio Fazio, Cardiovascular Therapeutics

Lectures

  • Cholesterol-Carrying Lipoproteins and Cardiovascular Risk: New Guidelines and Beyond 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Meeting the Needs of Patients, Not LDL-C Goals: The Role of PCSK9 Inhibitor 
    ENDO 2019 - New Orleans, LA - 3/25/2019
  • Familial Lipid Disorders: What Every Lipid-Savvy Endocrinologist Needs to Know 
    ENDO 2019 - New Orleans, LA - 3/23/2019
  • Join now to see all

Press Mentions

  • Erin Michos, MD, MHS, FASPC Is Named Co Editor-in-Chief of the American Journal of Preventive Cardiology
    Erin Michos, MD, MHS, FASPC Is Named Co Editor-in-Chief of the American Journal of Preventive CardiologyFebruary 17th, 2021
  • AACE/ACE Consensus Statement Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive Summary
    AACE/ACE Consensus Statement Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm – 2020 Executive SummaryDecember 28th, 2020
  • ASPC Launches New Journal Focused on Preventive Cardiology
    ASPC Launches New Journal Focused on Preventive CardiologyMarch 27th, 2020
  • Join now to see all

Hospital Affiliations